Laddar...
Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis
Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative therapy for relapsed/refractory and high-risk non-Hodgkin lymphoma (NHL). However, no large studies have evaluated allo-HCT utilization in elderly NHL patients (≥65 years). Using the CIBMTR registry, we report a time-trend analys...
Sparad:
| I publikationen: | Blood Cancer J |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group UK
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6890709/ https://ncbi.nlm.nih.gov/pubmed/31796726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-019-0261-1 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|